Gerard, Sarah E.
Herrmann, Jacob
Xin, Yi
Martin, Kevin T.
Rezoagli, Emanuele
Ippolito, Davide
Bellani, Giacomo
Cereda, Maurizio
Guo, Junfeng
Hoffman, Eric A.
Kaczka, David W.
Reinhardt, Joseph M.
Funding for this research was provided by:
National Institutes of Health (R01-HL142625)
Office of the Assistant Secretary of Defense for Health Affairs (W81XWH-16-1-0434)
Roy J. Carver Charitable Trust (19-5154)
Article History
Received: 23 September 2020
Accepted: 29 December 2020
First Online: 14 January 2021
Competing interests
: Drs. Hoffman and Reinhardt are co-founders and shareholders in VIDA Diagnostics, Inc., a medical imaging software spin-off from the University of Iowa. Dr. Guo is a shareholder in VIDA Diagnostics, Inc. Drs. Kaczka and Herrmann are co-founders and shareholders of OscillaVent, Inc. Dr. Gerard has no competing interests. Yi Xin has no competing interests. Kevin T. Martin has no competing interests. Dr. Rezoagli has no competing interests. Dr. Ippolito has no competing interests. Dr. Bellani has no competing interests. Dr. Cereda has no competing interests.